Back to search
Oligometastatic Prostate Cancer (OMPC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Oligometastatic Prostate Cancer (OMPC) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Oligometastatic Prostate Cancer (OMPC) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to evaluate the efficacy and safety of lutetium (177Lu) vipivotide tetraxetan (AAA617) in participants with oligometastatic prostat…
The investigators propose redefining this concept by focusing on volume rather than the number of metastases. To achieve this, the investigators aim to determin…
The goal of this clinical trial is to learn whether an experimental vaccine called pTVG-HP ("vaccine" or "DNA vaccine"), combined with a drug called nivolumab c…
The TA-P-OLIM Study (Percutaneous Thermo-Ablation of Prostate Cancer OligoMetastasis) is a prospective, interventional phase II study designed to evaluate the f…
Prostate cancer represents the second most common malignancy in men worldwide. Oligometastatic prostate cancer (OMPC), defined as a transitional state between l…